These 500 million doses of COVID-19 vaccines given to poorest nations are surely timely

To date, Pfizer and BioNTech have shipped 700 million doses to more than 100 countries or territories around the world. The companies have direct supply agreements in place with 122 countries and discussions are ongoing with many more on the supply of the companies’ COVID-19 vaccine.

  • PPI Staff

    New York & Mainz: Today’s announcement by Pfizer and BioNTech to donate Covid-19 vaccines, will help some of the poorest nations in its fight against the Covid-19 pandemic.

    Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) plan to provide the U.S. government at a not-for-profit price 500 million doses of COVID-19 vaccine, 200 million doses in 2021 and 300 million doses in the first half of 2022. The US government will, in turn, donate the Pfizer-BioNTech vaccine doses to low- and lower middle-income countries and organizations that support them.

    92 low- and lower middle-income countries will be benefited with the donation of Covid-19 vaccines. The U.S. government and the companies will work with COVAX to ensure these vaccines are delivered to the specified countries around the world in a way that is most efficient and equitable.

    Previously Pfizer and BioNTech announced to provide 2 billion doses of the Covid-19 vaccine to low- and middle-income countries over the next 18 months. The 500 million doses are just the beginning.

    “Our partnership with the U.S. government will help bring hundreds of millions of doses of our vaccine to the poorest countries around the world as quickly as possible. COVID-19 has impacted everyone, everywhere, and to win the battle against this pandemic, we must ensure expedited access to vaccines for all. I want to thank President Biden for his leadership in protecting the least advantaged of our global neighbors,” said Albert Bourla, Chairman and Chief Executive Officer, Pfizer. “Fair and equitable distribution has been our North Star since Day One and we are proud to do our part to help vaccinate the world, a massive but an achievable undertaking.”

    In a joint effort the private and the public sector are providing solutions to help end this pandemic. The companies are further committed to provide sustainable solutions by supporting the establishment of manufacturing network on various continents. “It is our goal to leverage our proprietary mRNA technology to help improve the health of people around the world,” said Ugur Sahin, M.D., CEO and Co-Founder of BioNTech.

    Deliveries of the 200 million doses will begin in August 2021 and continue through the remainder of the year. The 300 million doses for 2022 will be delivered between January and end of June 2022. The U.S. government also has the option for additional doses in 2022. The plan is to produce the doses being purchased by the U.S. government in Pfizer’s U.S. facilities.

    To date, Pfizer and BioNTech have shipped 700 million doses to more than 100 countries or territories around the world. The companies have direct supply agreements in place with 122 countries and discussions are ongoing with many more on the supply of the companies’ COVID-19 vaccine.

Recommended For You

Leave a Reply

Peoples Post India I India News